NeuroBo Pharmaceuticals Statistics

Total Valuation

NRBO has a market cap or net worth of $24.44 million. The enterprise value is -$3.43 million.

Market Cap	24.44M
Enterprise Value	-3.43M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, after market close.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

NRBO has 8.49 million shares outstanding. The number of shares has increased by 84.99% in one year.

Shares Outstanding	8.49M
Shares Change (YoY)	+84.99%
Shares Change (QoQ)	+6.67%
Owned by Insiders (%)	0.86%
Owned by Institutions (%)	3.03%
Float	2.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.25
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.01.

Current Ratio	2.94
Quick Ratio	2.89
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -117.35% and return on invested capital (ROIC) is -74.83%.

Return on Equity (ROE)	-117.35%
Return on Assets (ROA)	-57.24%
Return on Capital (ROIC)	-74.83%
Revenue Per Employee	n/a
Profits Per Employee	-$3.24M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.18% in the last 52 weeks. The beta is -0.30, so NRBO's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	-18.18%
50-Day Moving Average	3.28
200-Day Moving Average	3.97
Relative Strength Index (RSI)	46.11
Average Volume (20 Days)	58,935

Short Selling Information

The latest short interest is 32,440, so 0.38% of the outstanding shares have been sold short.

Short Interest	32,440
Short Previous Month	33,260
Short % of Shares Out	0.38%
Short % of Float	1.57%
Short Ratio (days to cover)	0.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.53M
Pretax Income	-16.58M
Net Income	-25.90M
EBITDA	-26.51M
EBIT	-26.53M
Earnings Per Share (EPS)	-$5.01

Full Income Statement

Balance Sheet

The company has $28.05 million in cash and $170,000 in debt, giving a net cash position of $27.88 million or $3.28 per share.

Cash & Cash Equivalents	28.05M
Total Debt	170,000
Net Cash	27.88M
Net Cash Per Share	$3.28
Equity (Book Value)	18.94M
Book Value Per Share	2.30
Working Capital	18.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.90 million and capital expenditures -$54,000, giving a free cash flow of -$19.95 million.

Operating Cash Flow	-19.90M
Capital Expenditures	-54,000
Free Cash Flow	-19.95M
FCF Per Share	-$2.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.99%
Shareholder Yield	-84.99%
Earnings Yield	-105.96%
FCF Yield	-81.64%

Analyst Forecast

The average price target for NRBO is $10.00, which is 247.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	247.22%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 21, 2023. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Dec 21, 2023
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1